Societal CDMO, Inc. Share Price Börse Stuttgart
Equities
RAH
US75629F1093
Pharmaceuticals
Sales 2022 | 90.21M 84.42M 7.54B | Sales 2023 | 94.64M 88.56M 7.91B | Capitalization | 36.73M 34.37M 3.07B |
---|---|---|---|---|---|
Net income 2022 | -19M -17.78M -1.59B | Net income 2023 | -13M -12.17M -1.09B | EV / Sales 2022 | 1.72 x |
Net Debt 2022 | 29.21M 27.34M 2.44B | Net Debt 2023 | 34.26M 32.06M 2.86B | EV / Sales 2023 | 0.75 x |
P/E ratio 2022 |
-4.34
x | P/E ratio 2023 |
-2.5
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.05% |
Latest transcript on Societal CDMO, Inc.
1st Jan change | Capi. | |
---|---|---|
+55.19% | 815B | |
+45.31% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+18.94% | 247B | |
+3.27% | 229B | |
+13.80% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |